IDEXX Laboratories, Inc. (BVMF:I1DX34)
| Market Cap | 255.32B +20.7% |
| Revenue (ttm) | 23.70B +10.4% |
| Net Income | 5.84B +19.3% |
| EPS | 72.04 +22.6% |
| Shares Out | n/a |
| PE Ratio | 43.75 |
| Forward PE | 41.74 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11 |
| Average Volume | 49 |
| Open | 637.08 |
| Previous Close | 651.07 |
| Day's Range | 637.08 - 637.08 |
| 52-Week Range | 439.00 - 813.60 |
| Beta | 1.70 |
| RSI | 34.48 |
| Earnings Date | May 8, 2026 |
About IDEXX Laboratories
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides com... [Read more]
Financial Performance
In 2025, IDEXX Laboratories's revenue was $4.30 billion, an increase of 10.42% compared to the previous year's $3.90 billion. Earnings were $1.06 billion, an increase of 19.33%.
Financial numbers in USD Financial StatementsNews
IDEXX Laboratories to Present at Two Institutional Investor Conferences
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 26, 9:55 am –...
IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results
IDEXX Laboratories Inc. (NASDAQ: IDXX) reported better-than-expected fourth-quarter financial results and issued a fiscal 2026 forecast on Monday.
IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics
Animal diagnostics maker IDEXX Laboratories on Monday forecast 2026 revenue and profit above Wall Street estimates, betting that resilient demand at veterinary clinics and higher testing per visit wil...
IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. Fourth Quarter and Full ...
Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
WESTBROOK, Maine--(BUSINESS WIRE)--ImageVue DR50 Plus introduces high-definition diagnostic imaging at the lowest dose of radiation, accelerating diagnosis and improving staff safety.
IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
WESTBROOK, Maine--(BUSINESS WIRE)--Cancer Dx Panel expansion and inVue Dx FNA cytology rollout advance veterinary cancer care, enabling comprehensive mast cell tumor testing for dogs.
IDEXX Announces CEO Succession
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the promotion of Michael (Mike) Erickson, PhD, to President an...
IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial r...
Final Trades: Palo Alto Networks, Capital One, Idexx Labs and the XLB
CNBC's “Halftime Report” Investment Committee discuss their top stocks to watch for the second half of the day's trading session.
IDEXX Laboratories Vs ResMed: Which Stock Could Rally?
IDEXX Laboratories' (IDXX) recent jump has investors questioning whether it's still the best bet—or if a stronger opportunity exists elsewhere. A closer look at its key competitor suggests there may b...
Final Trades: Meta, S&P Global and Idexx Lab
The Investment Committee give you their top stocks to watch for the second half.
Idexx Stock Pops on Earnings. Pet Health Is Booming.
Vet visits are down, but growing revenue per visit is more than making up for it, the company says.
Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook
IDEXX Laboratories Inc.‘s (NASDAQ:IDXX) stock is trading higher on Monday after it reported better-than-expected third-quarter financial results and raised its 2025 forecast.
IDEXX raises annual forecasts as pet owners spend more on preventive care
IDEXX Laboratories raised its full-year profit and revenue forecasts on Monday after reporting better third-quarter results than last year, as the pet diagnostics maker banks on owners spending more o...
IDEXX Laboratories Announces Third Quarter Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company repor...
IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
IDEXX Laboratories, Inc. (NASDAQ:IDXX) will release earnings results for the third quarter, before the opening bell on Monday, Nov. 3.
IDEXX Laboratories to Release 2025 Third Quarter Financial Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 third quarter financial results for Mond...
IDEXX Laboratories Elects Karen Peacock to Board of Directors
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Karen Peacock to the Company's Board of Direct...
IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and ...
S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes
Major U.S. equities indexes pushed higher at the top of the new trading week, bouncing back from declines posted ahead of the weekend. Although weaker-than-expected jobs data released on Friday raised...
Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF
The Investment Committee gives you their top stocks to watch for the second half.
Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More
U.S. equities were higher at midday, bouncing back from Friday's employment report-related selloff, and on news the European Union would delay new tariffs on U.S. goods. The Dow Jones Industrial Avera...
IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation
Pet healthcare is witnessing a surge in demand as more households prioritize their pets' well-being, driving companies in this sector to outperform expectations. This trend is reflected in IDEXX Labor...
IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook
Shares of IDEXX Laboratories (IDXX) soared more than 10% in premarket trading Monday after the pet health care company reported better-than-expected second-quarter results and raised its 2025 profit a...
IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics
IDEXX Laboratories raised its full-year profit and revenue forecasts on Monday after reporting better-than-expected second-quarter results, driven by strong demand for its veterinary diagnostic equipm...